Journal of Health Sciences and Medicine

Yazarlar: Ayşe AYYILDIZ, Nurdan ÇOBANER, Birgül YELKEN

Konular:Sağlık Bilimleri ve Hizmetleri

Anahtar Kelimeler:COVID-19,Sepsis induced coagulopathy,D-Dimer levels

Özet: Aim: This study was planned to compare the extent of hypercoagulopathic complications in COVID-19 pneumonia with that of last year's pneumonia cases which consist of by other agents. Material and Method: The data of patients with pneumosepsis due to non-COVID-19 causes between 01 April-30 June 2019 and COVID-19 pneumosepsis patients between 01 April-30 June 2020,were analyzed retrospectively. Demographic data, comorbidities, SOFA scores, SIC scores, D-dimer levels, coagulopathic complications, mortality and discharge status of patients diagnosed with pneumosepsis and treated in both periods were recorded Results: While sequential D-dimer measurements did not show a significant change in the 2019 group, it was observed that it increased significantly in the 2020 group (p<0.05). When we analyse the coagulopathic complications,we saw that submassive pulmonary embolism was recorded in one patient in the 2019 group.In the 2020 group, one patient had disseminated intravascular coagulation (DIC) and one patient had massive pulmonary embolism. Conclusion: In our study, we did not find a significant difference in SIC scores and mortality rates between pneumosepsis patients in last years and COVID-19 pneumosepsis patients.

---